FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $2.5B
1-Year Est. Return 52.94%
This Quarter Est. Return
1 Year Est. Return
+52.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.14B
AUM Growth
-$232M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$43.7M
2
+$38.3M
3
+$31.7M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$17.5M
5
SVRA icon
Savara
SVRA
+$16.8M

Top Sells

1
+$124M
2
+$52M
3
+$35.6M
4
GPCR icon
Structure Therapeutics
GPCR
+$27M
5
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$22.9M

Sector Composition

1 Healthcare 99.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$235M 10.99%
12,226,943
2
$222M 10.39%
6,495,392
3
$182M 8.49%
988,460
4
$154M 7.18%
10,617,062
+835,590
5
$104M 4.87%
10,109,279
6
$97.4M 4.55%
2,371,304
+181,125
7
$92M 4.3%
3,632,604
+217,000
8
$81.7M 3.82%
8,785,284
9
$79.1M 3.7%
1,754,834
+969,834
10
$78.5M 3.67%
1,039,405
-100,000
11
$67.2M 3.14%
3,731,067
+427,500
12
$54.3M 2.54%
2,165,591
+1,265,891
13
$47.9M 2.24%
3,314,349
+300,000
14
$43.4M 2.03%
3,687,867
15
$43.1M 2.02%
1,587,527
-200,000
16
$38.7M 1.81%
997,455
17
$38.3M 1.79%
+16,216,216
18
$37.6M 1.76%
871,974
+348,808
19
$35.7M 1.67%
875,667
20
$33.6M 1.57%
1,561,230
21
$32.9M 1.54%
8,157,385
+4,157,385
22
$29.3M 1.37%
4,142,855
23
$24.3M 1.14%
770,000
24
$24M 1.12%
1,502,788
25
$22.1M 1.03%
373,100
-373,379
1
2 3